Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles
New stock news | Deisai Bio successfully passed the hearing of the Hong Kong Stock Exchange, sprinting to become the "first stock of medical imaging big models".
C CARBONNEUTRAL(01372): Suntu Lithium Technology signs strategic cooperation agreement with Hubei Liming Lithium Industry
YUM CHINA (09987) spent HKD 7,728,900 on March 13 to repurchase 18,800 shares.
New stock news | Deisai Bio successfully passed the hearing of the Hong Kong Stock Exchange, sprinting to become the "first stock of medical imaging big models".
C CARBONNEUTRAL(01372): Suntu Lithium Technology signs strategic cooperation agreement with Hubei Liming Lithium Industry
YUM CHINA (09987) spent HKD 7,728,900 on March 13 to repurchase 18,800 shares.
